Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure

Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure

Background There are no studies of mineralocorticoid receptor antagonist (MRA) treatment examining outcome in unselected real‐life patients with myocardial infarction (MI) and heart failure (HF). There is uncertainty regarding effects of MRA in relation to left ventricular ejection fraction (LVEF) a...

Full description

Bibliographic Details
Main Authors: Ida Löfman, Karolina Szummer, Henrik Olsson, Juan‐Jesus Carrero, Lars H. Lund, Tomas Jernberg
Format: Article
Language:English
Published: Wiley 2018-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
ejection fraction
heart failure
mineralocorticoid receptor antagonists
myocardial infarction
prognosis
renal function
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009359

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.009359

Similar Items